JINYU: The gene-engineered subunit vaccine for bovine gas gangrene (Type A) has obtained a new veterinary drug registration certificate
I'm PortAI, I can summarize articles.
According to the announcement from JINYU, the company has been approved by the Ministry of Agriculture and Rural Affairs of the People's Republic of China to develop a new veterinary drug, the genetically engineered subunit vaccine for Clostridium perfringens type A, in collaboration with other companies through its wholly-owned subsidiary Jinyu Baoling Biological Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinyu Baoling"), in accordance with the national "Veterinary Drug Management Regulations" and "Veterinary Drug Registration Measures." The "New Veterinary Drug Registration Certificate" has been issued
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments